Carl Dambkowski
Chief Medical Officer; Director · 14 filings · Latest: Sep 2, 2026
Apogee Therapeutics, Inc.
Oruka Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APGE | Carl Dambkowski | Chief Medical Officer | Mar 4, 2026 | Sale | $71.06 | 5,500 | $390.8K | 209,773 | |
APGE | Carl Dambkowski | Chief Medical Officer | Mar 4, 2026 | Option Exercise | $22.86 | 4,125 | $94.3K | 215,273 | |
APGE | Carl Dambkowski | Chief Medical Officer | Feb 4, 2026 | Sale | $65.79 | 5,500 | $361.9K | 211,148 | |
APGE | Carl Dambkowski | Chief Medical Officer | Feb 4, 2026 | Option Exercise | $22.86 | 4,125 | $94.3K | 216,648 | |
APGE | CARL DAMBKOWSKI | — | Jan 7, 2026 | Proposed Sale | $78.25 | 35,200 | $2.8M | — | |
APGE | CARL DAMBKOWSKI | — | Dec 4, 2025 | Proposed Sale | $74.55 | 10,900 | $812.6K | — | |
APGE | CARL DAMBKOWSKI | — | Nov 5, 2025 | Proposed Sale | $53.90 | 10,785 | $581.3K | — | |
APGE | CARL DAMBKOWSKI | — | Jul 2, 2025 | Proposed Sale | $44.26 | 22,345 | $989.0K | — | |
APGE | CARL DAMBKOWSKI | — | Apr 2, 2025 | Proposed Sale | $35.61 | 9,310 | $331.5K | — | |
APGE | CARL DAMBKOWSKI | — | Dec 11, 2024 | Proposed Sale | $48.38 | 18,160 | $878.6K | — | |
APGE | CARL DAMBKOWSKI | — | Oct 2, 2024 | Proposed Sale | $57.31 | 16,010 | $917.5K | — |
← Previous
Page 2 of 2